Drugs / Star-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04081597 | Feb → Mar 2020 | — | Acanthas Pharma Inc | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Star-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04081597 ↗ |
| Route | Oral | “Administered orally” NCT04081597 ↗ |